Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis

被引:138
作者
de Gouville, AC
Boullay, V
Krysa, G
Pilot, J
Brusq, JM
Loriolle, F
Gauthier, JM
Papworth, SA
Laroze, A
Gellibert, F
Huet, S
机构
[1] GlaxoSmithKline, Dept Biol, F-91951 Les Ulis, France
[2] GlaxoSmithKline, Dept Pathol, Ware SG12 0DP, Herts, England
[3] GlaxoSmithKline, Dept Med Chem, F-91951 Les Ulis, France
关键词
hepatectomy; collagen; ALK5; hepatic stellate cells; liver fibrosis; DMN; TGF-beta; GW6604;
D O I
10.1038/sj.bjp.0706172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Chronic liver disease is characterized by an exacerbated accumulation of matrix, causing progressive fibrosis, which may lead to cirrhosis. Transforming growth factor beta (TGF-β), a well-known profibrotic cytokine, transduces its signal through the ALK5 ser/thr kinase receptor, and increases transcription of different genes including PAI-1 and collagens. The identification of GW6604 (2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine), an ALK5 inhibitor, allowed us to evaluate the therapeutic potential of inhibiting TGF-β pathway in different models of liver disease. 2 A cellular assay was used to identify GW6604 as a TGF-β signaling pathway inhibitor. This ALK5 inhibitor was then tested in a model of liver hepatectomy in TGF-β-overexpressing transgenic mice, in an acute model of liver disease and in a chronic model of dimethylnitrosamine (DMN)-induced liver fibrosis. 3 In vitro, GW6604 inhibited autophosphorylation of ALK5 with an IC50 of 140 nM and in a cellular assay inhibited TGF-β-induced transcription of PAI-1 (IC50: 500 nM). In vivo, GW6604 (40 mg kg(-1) p.o.) increased liver regeneration in TGF-β-overexpressing mice, which had undergone partial hepatectomy. In an acute model of liver disease, GW6604 reduced by 80 % the expression of collagen IA1. In a chronic model of DMN-induced fibrosis where DMN was administered for 6 weeks and GW6604 dosed for the last 3 weeks (80 mg kg(-1) p.o., b.i.d.), mortality was prevented and DMN-induced elevations of mRNA encoding for collagen IA1,IA2, III, TIMP-1 and TGF-b were reduced by 50 - 75 %. Inhibition of matrix genes overexpression was accompanied by reduced matrix deposition and reduction in liver function deterioration, as assessed by bilirubin and liver enzyme levels. 4 Our results suggest that inhibition of ALK5 could be an attractive new approach to treatment of liver fibrotic diseases by both preventing matrix deposition and promoting hepatocyte regeneration.
引用
收藏
页码:166 / 177
页数:12
相关论文
共 51 条
[11]   Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene [J].
Eitzman, DT ;
McCoy, RD ;
Zheng, XX ;
Fay, WP ;
Shen, TL ;
Ginsburg, D ;
Simon, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :232-237
[12]   CLONING OF A TGF-BETA TYPE-I RECEPTOR THAT FORMS A HETEROMERIC COMPLEX WITH THE TGF-BETA TYPE-II RECEPTOR [J].
FRANZEN, P ;
TENDIJKE, P ;
ICHIJO, H ;
YAMASHITA, H ;
SCHULZ, P ;
HELDIN, CH ;
MIYAZONO, K .
CELL, 1993, 75 (04) :681-692
[13]   2,4,5-TRIARYLIMIDAZOLE INHIBITORS OF IL-1 BIOSYNTHESIS [J].
GALLAGHER, TF ;
FIERTHOMPSON, SM ;
GARIGIPATI, RS ;
SORENSON, ME ;
SMIETANA, JM ;
LEE, D ;
BENDER, PE ;
LEE, JC ;
LAYDON, JT ;
GRISWOLD, DE ;
CHABOTFLETCHER, MC ;
BRETON, JJ ;
ADAMS, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (11) :1171-1176
[14]  
GELLIBERT FJ, 2002, Patent No. 0266462
[15]   Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen [J].
George, J ;
Rao, KR ;
Stern, R ;
Chandrakasan, G .
TOXICOLOGY, 2001, 156 (2-3) :129-138
[16]   Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine [J].
George, J ;
Chandrakasan, G .
CLINICAL BIOCHEMISTRY, 2000, 33 (07) :563-570
[17]   RELATIONSHIP BETWEEN PROCOLLAGEN-III AMINOTERMINAL PROPEPTIDE AND HYALURONAN SERUM LEVELS AND HISTOLOGICAL FIBROSIS IN PRIMARY BILIARY-CIRRHOSIS AND CHRONIC VIRAL-HEPATITIS-C [J].
GUECHOT, J ;
POUPON, RE ;
GIRAL, P ;
BALKAU, B ;
GIBONDEAU, J ;
POUPON, R .
JOURNAL OF HEPATOLOGY, 1994, 20 (03) :388-393
[18]   Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12 [J].
Huse, M ;
Chen, YG ;
Massagué, J ;
Kuriyan, J .
CELL, 1999, 96 (03) :425-436
[19]   SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 [J].
Inman, GJ ;
Nicolás, FJ ;
Callahan, JF ;
Harling, JD ;
Gaster, LM ;
Reith, AD ;
Laping, NJ ;
Hill, CS .
MOLECULAR PHARMACOLOGY, 2002, 62 (01) :65-74
[20]   HISTOPHOTOMETRIC ESTIMATION OF VOLUME DENSITY OF COLLAGEN AS AN INDICATION OF FIBROSIS IN RAT-LIVER [J].
JAMES, J ;
BOSCH, KS ;
ZUYDERHOUD, FMJ ;
HOUTKOOPER, JM ;
VANGOOL, J .
HISTOCHEMISTRY, 1986, 85 (02) :129-133